NCT05483075Completed
Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer
An Exploratory Study Evaluating the Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer With Biological Correlative Studies
Source: ClinicalTrials.gov · Last updated 2 May 2025
Brief summary (registry, in English)
Pilot study evaluating the feasibility of a 2-4 week health care provider guided exercise intervention prior to surgery for pancreatic cancer.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 16 (actual)
- First submitted
- 29 Jul 2022
- Start date
- 15 Nov 2022
- Primary completion date
- 13 Aug 2024
- Lead sponsor
- NYU Langone Health
- Diseases
- Pancreatic cancer
- NCT number
- NCT05483075
What you commit to
- Study type: Interventional
- Participants enrolled: 16
- From 15 Nov 2022 to the primary completion date, 13 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Inability to complete physical activity due to recent injury or surgery
Other illness
- Evidence of metastatic disease
- Uncontrolled heart disease limiting physical activity
Other
- Participation in another interventional trial that excludes participation in this protocol
- Subjects who anticipate undergoing a procedure during the course of the trial that will render them unable to engage in physical activity for more than 48 hours
- Pregnant subjects
- Individuals who lack the capacity to consent
Who the study is looking for
- Willingness and ability to participate in the study procedures
- Pathologically confirmed pancreatic cancer
- Candidate for neoadjuvant therapy followed by surgical resection with potentially curative intent. Note: There is no limitation on duration of neoadjuvant therapy.
- Planned to have at least 2 weeks after completing the last neoadjuvant therapy and surgery
- Over the age of 18
- Ability to engage in physical activity as determined by physiatrist review after completion of the Physical Activity Readiness questionnaire (PAR-Q) exercise survey and chart review
- Agree to study blood draws and tissue collection
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health Ambulatory Care Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.